Overall patients | Matched population | |||||
---|---|---|---|---|---|---|
Survival group (N = 42) | Death group (N = 16) | P value | Survival group (N = 15) | Death group (N = 15) | P value | |
Sex, male | 36(85.71%) | 12(75%) | 0.564 | 14(93.33%) | 11(73.33%) | 0.330 |
Age, years | 64.67 ± 8.02 | 63.75 ± 10.10 | 0.719 | 63.13 ± 6.90 | 63.533 ± 10.41 | 0.902 |
BMI, kg/m2 | 24.02 ± 3.23 | 26.24 ± 3.52A | 0.030 | 24.53 ± 3.22 | 26.24 ± 3.52 | 0.062 |
Hypertension | 25(59.52%) | 11(68.75%) | 0.517 | 6(40%) | 11(73.33%) | 0.139 |
Diabetes | 17(40.48%) | 7(43.75%) | 0.821 | 4(26.67%) | 6(40%) | 0.700 |
Carotid artery stenosis | 17(47.22%)D | 9(69.23%)C | 0.173 | 8(53.33%) | 9(69.23%)B | 0.560 |
Cerebral infarction | 8(19.05%) | 5(31.25%) | 0.520 | 4(26.67%) | 5(33.33%) | 1.000 |
Heart insufficiency | 10(23.81%) | 10(66.67%)A | 0.003 | 4(26.67%) | 10(66.67%) | 0.066 |
Respiratory insufficiency | 17(47.22%)D | 6(42.86%)B | 0.781 | 4(26.67%) | 5(33.33%)B | 1.000 |
Hepatic insufficiency | 11(27.5%)B | 4(26.67%)A | 1.000 | 4(26.67%) | 4(26.67%) | 1.000 |
Renal insufficiency | 7(17.5%)B | 2(13.33%)A | 0.895 | 0(0%) | 2(13.33%) | 0.483 |
Time between myocardial infarction and surgery, days, (Q1–Q3) | 14(10–16) | 11.50(7.25–17.75) | 0.239 | 15.67 ± 7.05 | 13.6 ± 7.64 | 0.239 |